Abstract
Atherogenic dyslipidemia in type 2 diabetes mellitus is a significant modifiable factor for cardiovascular disease (CVD), contributing to a high risk of morbidity and mortality. Poor glycemic control in diabetic patients is considered a secondary cause of dyslipidemia, with data from earlier studies indicating that it is a predictor of dyslipidemia, with higher total cholesterol (TC), trigerylcerides (TG), low density lipoprotein (LDL), and decreased high density lipoprotein (HDL). Dyslipidemia is a modifiable risk factor for CVD, thus understanding its impact is critical.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
